A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2011

Conditions
Human Immunodeficiency Virus-1
Interventions
DRUG

maraviroc

maraviroc (Selzentry, Celsentri) 150mg QD + atazanavir (Reyataz) /ritonavir (Norvir) (300/100mg) QD OR maraviroc (Selzentry, Celsentri) 150mg QD+ darunavir (Prezista)/ritonavir (Norvir) (800/100 mg) QD (if atazanavir (Reyataz) /ritonavir (Norvir) is replaced by darunavir (Prezista)/ritonavir (Norvir)) OR maraviroc (Selzentry, Celsentri) 150mg QD+ lopinavir/ritonavir (Kaletra, Aluvia) (400/100 mg) BID (if atazanavir (Reyataz) /ritonavir (Norvir) is replaced by lopinavir/ritonavir (Kaletra, Aluvia))

DRUG

maraviroc

emtricitabine/tenofovir (Truvada) 200/300mg QD + atazanavir (Reyataz) /ritonavir (Norvir) 300/100 mg QD OR emtricitabine/tenofovir (Truvada) 200/300 mg QD + darunavir (Prezista)/ritonavir (Norvir) (800/100 mg) QD (if atazanavir (Reyataz) /ritonavir (Norvir) is replaced by darunavir (Prezista)/ritonavir (Norvir)) OR emtricitabine/tenofovir (Truvada) 200/300 mg QD + lopinavir/ritonavir(Kaletra, Aluvia) (400/100 mg) BID (if atazanavir (Reyataz) /ritonavir (Norvir) is replaced by lopinavir/ritonavir (Kaletra, Aluvia))

Trial Locations (39)

10003

Pfizer Investigational Site, New York

10243

Pfizer Investigational Site, Berlin

12157

Pfizer Investigational Site, Berlin

14004

Pfizer Investigational Site, Córdoba

20009

Pfizer Investigational Site, Washington D.C.

20146

Pfizer Investigational Site, Hamburg

28046

Pfizer Investigational Site, Madrid

28078

Pfizer Investigational Site, Huntersville

30312

Pfizer Investigational Site, Atlanta

32504

Pfizer Investigational Site, Pensacola

32803

Pfizer Investigational Site, Orlando

33133

Pfizer Investigational Site, Miami

33136

Pfizer Investigational Site, Miami

33137

Pfizer Investigational Site, Miami

33602

Pfizer Investigational Site, Tampa

33614

Pfizer Investigational Site, Tampa

33713

Pfizer Investigational Site, St. Petersburg

41013

Pfizer Investigational Site, Seville

48109

Pfizer Investigational Site, Ann Arbor

50937

Pfizer Investigational Site, Cologne

60590

Pfizer Investigational Site, Frankfurt am Main

60657

Pfizer Investigational Site, Chicago

68106

Pfizer Investigational Site, Omaha

75001

Pfizer Investigational Site, Addison

75204

Pfizer Investigational Site, Dallas

75390

Pfizer Investigational Site, Dallas

77098

Pfizer Investigational Site, Houston

80335

Pfizer Investigational Site, München

90027

Pfizer Investigational Site, Los Angeles

90028

Pfizer Investigational Site, Los Angeles

90048

Pfizer Investigational Site, Los Angeles

90069

Pfizer Investigational Site, Los Angeles

99204

Pfizer Investigational Site, Spokane

06851

Pfizer Investigational Site, Norwalk

01107

Pfizer Investigational Site, Springfield

01199

Pfizer Investigational Site, Springfield

03010

Pfizer Investigational Site, Alicante

08036

Pfizer Investigational Site, Barcelona

08907

Pfizer Investigational Site, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

ViiV Healthcare

INDUSTRY